Synergistic effects of metformin and curcumin on cytotoxicity of chemotherapy drugs using a gastric cancer cell line model

Authors

  • Ehsan Zarei Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran https://orcid.org/0000-0001-5284-1133
  • Youssof Sefidi-Heris Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
  • Iraj Saadat Department of Biology, College of Sciences, Shiraz University, Shiraz 71467-13565, Iran. Tel: +98 71 36137435, E-mail: isaadat@shirazu.ac.ir https://orcid.org/0000-0002-8169-4707

DOI:

https://doi.org/10.17179/excli2021-4091

Keywords:

gastric cancer, metformin, curcumin, chemotherapy, synergistic effect

Abstract

Gastric cancer has a weak prognosis and its usual treatments depend on surgery and chemotherapy. These treatments suffer from some drawbacks such as high rates of local recurrence and metastasis, low survival rates, and significantly decreased life quality. Therefore, new therapeutic methods for improved gastric cancer care with minimal side effects seem necessary. Currently, combinatorial treatments for cancer are preferred and recently, metformin (Met) and curcumin (Cur) have been interesting options for this type of therapy. The aim of the present study was to investigate anticancer effects of metformin and curcumin in both single and combinatorial treatment forms on AGS gastric cancer cell line. In comparison to single treatments with each substance, the results of co-treatments with metformin and curcumin indicated synergistic inhibitory effects on cell viability, wound healing, cell migration and invasion, and primary tumor formation. To determine the selective effect of combination of “Met + Cur” on cancerous cells, very low doses of 8 anticancer drugs (cisplatin, carboplatin, oxaliplatin, epirubicin, doxorubicin, docetaxel, paclitaxel, and methotrexate) used in MTT assay were comparatively tested on AGS cancer cells and normal HDF cells for 48 and 72 hours. The results indicated that the combination of “Met + Cur” significantly increased cytotoxic effects of all anticancer drugs of AGS cells. It is while in normal HDF cells, combination of “Met + Cur” along with anticancer drugs had no effect. This can be inferred as selectively additive effect.

Downloads

Additional Files

Published

2021-10-11

How to Cite

Zarei, E. ., Sefidi-Heris, Y. ., & Saadat, I. (2021). Synergistic effects of metformin and curcumin on cytotoxicity of chemotherapy drugs using a gastric cancer cell line model. EXCLI Journal, 20, 1488–1498. https://doi.org/10.17179/excli2021-4091

Issue

Vol. 20 (2021)

Section

Original articles

License

Copyright (c) 2021 Ehsan Zarei, Youssof Sefidi-Heris, Iraj Saadat

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).